Osteoporotic bone of miR-150-deficient mice: Possibly due to low serum OPG-mediated osteoclast activation

Bezman, 2011, miR-150 regulates the development of NK and iNKT cells, J. Exp. Med., 208, 2717, 10.1084/jem.20111386 Bouxsein, 2010, Guidelines for assessment of bone microstructure in rodents using micro-computed tomography, J. Bone Miner. Res., 25, 1468, 10.1002/jbmr.141 Boyle, 2003, Osteoclast differentiation and activation, Nature, 423, 337, 10.1038/nature01658 Bucay, 1998, osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification, Genes Dev., 12, 1260, 10.1101/gad.12.9.1260 Choi, 2001, Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells, Eur. J. Immunol., 31, 2179, 10.1002/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X Choi, 2012, Fisetin inhibits osteoclast differentiation via downregulation of p38 and c-Fos-NFATc1 signaling pathways, Evid. Based Complement. Alternat. Med., 2012, 810563, 10.1155/2012/810563 Dempster, 2013, Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee, J. Bone Miner. Res., 28, 2, 10.1002/jbmr.1805 Gamez, 2014, MicroRNAs and post-transcriptional regulation of skeletal development, J. Mol. Endocrinol., 52, R179, 10.1530/JME-13-0294 Hu, 2011, Activated invariant NKT cells regulate osteoclast development and function, J. Immunol., 186, 2910, 10.4049/jimmunol.1002353 Kagiya, 2013, Expression profiling of microRNAs in RAW264.7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation, J. Periodontal Res., 48, 373, 10.1111/jre.12017 Kamolmatyakul, 2001, Interferon-gamma down-regulates gene expression of cathepsin K in osteoclasts and inhibits osteoclast formation, J. Dent. Res., 80, 351, 10.1177/00220345010800011001 Li, 2007, B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo, Blood, 109, 3839, 10.1182/blood-2006-07-037994 Long, 2012, Osteoimmunology: the expanding role of immunoreceptors in osteoclasts and bone remodeling, Bonekey Rep., 1, 10.1038/bonekey.2012.59 Lu, 2008, MicroRNA-mediated control of cell fate in megakaryocyte–erythrocyte progenitors, Dev. Cell, 14, 843, 10.1016/j.devcel.2008.03.012 Mi, 2012, Lack of microRNA miR-150 reduces the capacity of epidermal Langerhans cell cross-presentation, Exp. Dermatol., 21, 876, 10.1111/exd.12008 Papaioannou, 2014, MicroRNAs involved in bone formation, Cell. Mol. Life Sci., 71, 4747, 10.1007/s00018-014-1700-6 Popoff, 1991, Coexistence of reduced function of natural killer cells and osteoclasts in two distinct osteopetrotic mutations in the rat, J. Bone Miner. Res., 6, 263, 10.1002/jbmr.5650060308 Pugliese, 2012, B-1 lymphocytes differentiate into functional osteoclast-like cells, Immunobiology, 217, 336, 10.1016/j.imbio.2011.07.014 Roundy, 2003, Overexpression of RANKL implicates IFN-beta-mediated elimination of B-cell precursors in the osteopetrotic bone of microphthalmic mice, J. Bone Miner. Res., 18, 278, 10.1359/jbmr.2003.18.2.278 Seeliger, 2014, Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures, J. Bone Miner. Res., 29, 1718, 10.1002/jbmr.2175 Seeling, 2013, Inflammatory monocytes and Fcgamma receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice, Proc. Natl. Acad. Sci. U. S. A., 110, 10729, 10.1073/pnas.1301001110 Simonet, 1997, Osteoprotegerin: a novel secreted protein involved in the regulation of bone density, Cell, 89, 309, 10.1016/S0092-8674(00)80209-3 Soderstrom, 2010, Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis, Proc. Natl. Acad. Sci. U. S. A., 107, 13028, 10.1073/pnas.1000546107 Takahashi, 1986, Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells, J. Immunol., 137, 3544, 10.4049/jimmunol.137.11.3544 Takayanagi, 2007, Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems, Nat. Rev. Immunol., 7, 292, 10.1038/nri2062 Titanji, 2014, Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection, PLoS Pathog., 10, 10.1371/journal.ppat.1004497 van der Eerden, 2014, MicroRNAs in the skeleton: cell-restricted or potent intercellular communicators?, Arch. Biochem. Biophys., 561, 46, 10.1016/j.abb.2014.04.016 van Wijnen, 2013, MicroRNA functions in osteogenesis and dysfunctions in osteoporosis, Curr. Osteoporos. Rep., 11, 72, 10.1007/s11914-013-0143-6 Xia, 2011, MicroRNAs and their roles in osteoclast differentiation, Front. Med., 5, 414, 10.1007/s11684-011-0168-0 Xiao, 2007, MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb, Cell, 131, 146, 10.1016/j.cell.2007.07.021 Yun, 2001, Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function, J. Immunol., 166, 1482, 10.4049/jimmunol.166.3.1482 Zheng, 2012, MicroRNA miR-150 is involved in Valpha14 invariant NKT cell development and function, J. Immunol., 188, 2118, 10.4049/jimmunol.1103342 Zhou, 2007, miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely, Proc. Natl. Acad. Sci. U. S. A., 104, 7080, 10.1073/pnas.0702409104